Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Y. Hirose is active.

Publication


Featured researches published by Y. Hirose.


European Urology Supplements | 2013

E80 Administration of the selective alpha 1A adrenoceptor antagonist silodosin facilitates expulsion of size 5–10 mm distal ureteral stones, as compared to control

Y. Itoh; A. Okada; K. Taguchi; Y. Hirose; K. Niimi; Y. Fujii; T. Kobayashi; M. Usami; S. Hamamoto; R. Ando; M. Hirose; T. Yasui; K. Tozawa; K. Kohri

Objective nRecently, we reported that alpha 1A-adrenoceptor (AR) is the main participant in phenylephrine-induced human ureteral contraction. We therefore decided to carry out a prospective randomized study to evaluate the effects of silodosin, a selective alpha 1A AR antagonist, as a medical expulsive therapy (MET) for distal ureteral stones.


European Urology Supplements | 2014

803 M2 macrophages eliminate renal crystals by phagocytosis

K. Taguchi; A. Okada; T. Yasui; S. Iwatsuki; T. Hamakawa; Y. Hirose; S. Hamamoto; R. Ando; Y. Itoh; K. Tozawa; K. Kohri


European Urology Supplements | 2014

804 PPAR-α/γ agonists have different effects on renal crystal formation in hyperoxaluric animal models

K. Taguchi; A. Okada; T. Yasui; S. Iwatsuki; T. Hamakawa; Y. Hirose; T. Kobayashi; S. Hamamoto; R. Ando; Y. Itoh; K. Tozawa; K. Kohri


European Urology Supplements | 2013

E18 Association of the loci 5q35.3, 7q14.3, and 13.q14.1 with urolithiasis in the Japanese population

T. Yasui; A. Okada; M. Usami; Y. Hirose; Y. Ito; K. Taguchi; Y. Fujii; K. Niimi; S. Hamamoto; R. Ando; M. Hirose; Y. Itoh; K. Tozawa; Y. Higashi; Y. Sato; K. Matsuda; K. Kohri


European Urology Supplements | 2013

E184 M2 macrophages phagocytose renal calcium oxalate crystals and suppress crystal formation in a colony-stimulating factor-1-dependent manner

K. Taguchi; A. Okada; T. Yasui; Y. Hirose; K. Niimi; S. Hamamoto; Y. Itoh; K. Tozawa; K. Kohri


European Urology Supplements | 2013

311 Active phagocytosis and processing of calcium oxalate monohydrate crystals in an in vitro macrophage model

A. Okada; T. Yasui; L. Zuo; K. Taguchi; Y. Fujii; Y. Itoh; Y. Hirose; M. Usami; K. Niimi; R. Ando; T. Kobayashi; S. Hamamoto; M. Hirose; K. Tozawa; K. Kohri


European Urology Supplements | 2013

E88 Macrophage-derived cytokines and chemokines may be novel markers to predict calcium oxalate stone formation in humans

A. Okada; T. Yasui; K. Taguchi; Y. Ito; Y. Hirose; Y. Fujii; K. Niimi; M. Usami; T. Kobayashi; S. Hamamoto; M. Hirose; Y. Itoh; K. Tozawa; K. Kohri


European Urology Supplements | 2012

856 Calcium oxalate crystals could be englobed by macrophages during kidney stone formation in vitro and in vivo models

A. Okada; K. Taguchi; Y. Hirose; K. Niimi; Y. Fujii; T. Kobayashi; M. Usami; S. Hamamoto; M. Hirose; Y. Itoh; T. Yasui; K. Tozawa; K. Kohri


European Urology Supplements | 2012

952 Efficacy of Dornier official technical training for SWL treatment at the university hospital

S. Hamamoto; A. Okada; K. Taguchi; Y. Hirose; K. Niimi; Y. Fujii; R. Ando; T. Kobayashi; M. Usami; M. Hirose; Y. Itoh; T. Yasui; K. Tozawa; K. Kohri


European Urology Supplements | 2011

E17 Opening of mitochondrial permeability transition pores induces kidney stone formation

K. Niimi; T. Yasui; K. Taguchi; Y. Fujii; Y. Hirose; T. Kobayashi; S. Hamamoto; M. Hirose; A. Okada; Y. Itoh; K. Tozawa; K. Kohri

Collaboration


Dive into the Y. Hirose's collaboration.

Researchain Logo
Decentralizing Knowledge